Pentamidine Isethionate
NDC 13925-515, Pentamidine Isethionate, injection, powder, lyophilized, for solution, from Seton Pharmaceuticals.
- Product NDC
- 13925-515
- Status
- Listed
- Labeler
- Seton Pharmaceuticals
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206666
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13925-515 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PENTAMIDINE ISETHIONATE300 mg/300mg
Pharmacologic classes
Antiprotozoal [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13925-515-10 | 13925051510 | 10 VIAL in 1 TRAY (13925-515-10) / 300 mg in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cb8e8155-5505-44d5-9dee-525e2e45b95d
Use it
Look up 13925-515 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13925-515 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13925-515. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.